Cita APA (7a ed.)

Bolotina, L. V. (2020). Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma. IP Habib O.N.

Cita Chicago Style (17a ed.)

Bolotina, L. V. Lenvatinib as the Key Component of First-line Therapy for Patients with Unresectable Hepatocellular Carcinoma. IP Habib O.N, 2020.

Cita MLA (8a ed.)

Bolotina, L. V. Lenvatinib as the Key Component of First-line Therapy for Patients with Unresectable Hepatocellular Carcinoma. IP Habib O.N, 2020.